Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (30.523)

91

Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors : network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial

enthalten in: Current medical research and opinion | 2019

von Reyes, A. | Révil, C. | Niggli, M. | +10

CommentIn: Curr Med Res Opin. 2020 Jul;36(7):1129-1130. - PMID 32180474

92

FDA Approval Summary : Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kasamon, Y. | Chen, H. | de Claro, R. | +5

CommentIn: Clin Cancer Res. 2019 Dec 15;25(24):7272-7274. - PMID 31615932

93

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia : A Phase 3, Single-Arm, International Trial

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2019

von Insogna, K. | Rauch, F. | Kamenický, P. | +7

94

Safety and efficacy of fulranumab in osteoarthritis of the hip and knee : results from four early terminated phase III randomized studies

enthalten in: Current medical research and opinion | 2019

von Kelly, K. | Sanga, P. | Zaki, N. | +4

95

A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab

enthalten in: Internal medicine (Tokyo, Japan) | 2019

von Nara, M. | Saito, M. | Abe, F. | +3

96

A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Song, Y. | Wu, J. | Chen, X. | +15

97

Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer

enthalten in: Internal medicine (Tokyo, Japan) | 2019

von Yamagata, S. | Kageyama, K. | Takayasu, S. | +4

98

ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Srideshikan, S. | Brooks, J. | Zuro, D. | +20

99

Are neutralising anti-VEGF or VEGFR2 antibodies necessary in the treatment of EGFR-mutated non-small-cell lung cancer?

enthalten in: The Lancet. Oncology | 2019

von Rosell, R. | Pedraz-Valdunciel, C.

CommentOn: Lancet Oncol. 2019 Dec;20(12):1655-1669. - PMID 31591063

100

Mogamulizumab Forecast : Clearer Patients, with a Slight Chance of Immune Mayhem

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Larocca, C. | Kupper, T. | LeBoeuf, N.

CommentOn: Clin Cancer Res. 2019 Dec 15;25(24):7275-7280. - PMID 31366601